• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫喷妥钠与重症患者埃索美拉唑的相互作用。

Interaction of thiopental with esomeprazole in critically ill patients.

机构信息

Service de Pharmacologie Médicale et Clinique APHM, Aix Marseille Université, Marseille, France.

出版信息

Eur J Clin Pharmacol. 2013 Sep;69(9):1667-72. doi: 10.1007/s00228-013-1527-3. Epub 2013 May 30.

DOI:10.1007/s00228-013-1527-3
PMID:23719968
Abstract

INTRODUCTION

Thiopental is a thiobarbiturate given in the case of brain injuries to reduce intracranial pressure and to manage cerebral ischemia. A pharmacokinetic model has been described previously in critically ill patients with a different therapeutic strategy. New treatment options prompted us to investigate if drug-drug interactions occur. A new model is proposed describing the influence of concomitant administration of esomeprazole on the distribution of thiopental.

METHOD

The study population comprised 52 critically ill patients (body weight 47.1-114 kg) aged 18-78 years who had been admitted into the critical care unit for treatment of intracranial hypertension. A total mean dose of 282.8 ± 172.7 mg/kg was given in 96 ± 72 h. Pharmacokinetic analysis was performed by using a nonlinear mixed-effect population model.

RESULT

A one-compartment open model with first-order elimination identified two covariates, namely, body weight on clearance and volume of distribution, and the administration of esomeprazole on volume of distribution. The mean values (% relative standard error) for total clearance (CL) and for central volume of distribution (Vd) in patients with and without concomitant esomeprazole were 5.3 L/h (9.2 %) and 256.1 (6.4 %) and 153.2 l (19.2 %), respectively.

CONCLUSION

Based on these results, we conclude that concomitant administration of esomeprazole increases the volume of distribution and the half-live of thiopental. This drug-drug interaction should be considered when a target concentration has to be reached.

摘要

简介

硫喷妥钠是一种硫代巴比妥酸盐,用于治疗脑损伤以降低颅内压和治疗脑缺血。先前已经在采用不同治疗策略的危重病患者中描述了药代动力学模型。新的治疗选择促使我们研究是否存在药物相互作用。提出了一个新的模型来描述伴随给予埃索美拉唑对硫喷妥钠分布的影响。

方法

研究人群包括 52 名年龄在 18-78 岁的重症患者(体重 47.1-114 公斤),他们因颅内高压而入住重症监护病房接受治疗。在 96±72 小时内给予了 282.8±172.7mg/kg 的平均总剂量。通过非线性混合效应群体模型进行药代动力学分析。

结果

一个具有一级消除的单室开放模型确定了两个协变量,即清除率的体重和分布容积,以及埃索美拉唑的给予对分布容积的影响。伴有和不伴有伴随埃索美拉唑的患者的总清除率(CL)和中央分布容积(Vd)的平均值(%相对标准误差)分别为 5.3 L/h(9.2%)和 256.1(6.4%)和 153.2 l(19.2%)。

结论

基于这些结果,我们得出结论,伴随给予埃索美拉唑会增加硫喷妥钠的分布容积和半衰期。在需要达到目标浓度时,应考虑这种药物相互作用。

相似文献

1
Interaction of thiopental with esomeprazole in critically ill patients.硫喷妥钠与重症患者埃索美拉唑的相互作用。
Eur J Clin Pharmacol. 2013 Sep;69(9):1667-72. doi: 10.1007/s00228-013-1527-3. Epub 2013 May 30.
2
Pharmacokinetics of high-dose thiopental in pediatric patients with increased intracranial pressure.
Ther Drug Monit. 1997 Feb;19(1):63-70. doi: 10.1097/00007691-199702000-00011.
3
Comparison between esomeprazole 20 mg Vs 40 mg as stress ulcer prophylaxis (SUP) in critically ill patients: A retrospective cohort study.埃索美拉唑 20mg 与 40mg 预防危重症患者应激性溃疡(SUP)的效果比较:一项回顾性队列研究。
Pharmacol Res Perspect. 2020 Aug;8(4):e00624. doi: 10.1002/prp2.624.
4
Population pharmacokinetics of high-dose thiopental in patients with cerebral injuries.大剂量硫喷妥钠在脑损伤患者中的群体药代动力学。
Clin Pharmacol Ther. 1997 Jul;62(1):15-20. doi: 10.1016/S0009-9236(97)90147-8.
5
Thiopental in CSF and serum correlates with prolonged loss of cortical activity.
Eur Neurol. 1998;39(4):223-8. doi: 10.1159/000007938.
6
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%.丙泊酚用于重症患者长期镇静的群体药代动力学和药效学建模:丙泊酚6%与丙泊酚1%的比较
Clin Pharmacol Ther. 2002 Dec;72(6):670-84. doi: 10.1067/mcp.2002.129500.
7
Pharmacodynamics and pharmacokinetics of thiopental.硫喷妥钠的药效学与药代动力学。
Clin Pharmacokinet. 1998 Aug;35(2):95-134. doi: 10.2165/00003088-199835020-00002.
8
Comparative population pharmacokinetics of lorazepam and midazolam during long-term continuous infusion in critically ill patients.危重症患者长期持续输注劳拉西泮和咪达唑仑的比较群体药代动力学
Br J Clin Pharmacol. 2004 Feb;57(2):135-45. doi: 10.1046/j.1365-2125.2003.01957.x.
9
Semi-mechanistic autoinduction model of midazolam in critically ill patients: population pharmacokinetic analysis.危重症患者咪达唑仑的半机制自动诱导模型:群体药代动力学分析
J Clin Pharm Ther. 2016 Aug;41(4):392-8. doi: 10.1111/jcpt.12395. Epub 2016 May 12.
10
The pharmacokinetics, pharmacodynamics and safety of oral doses of ilaprazole 10, 20 and 40 mg and esomeprazole 40 mg in healthy subjects: a randomised, open-label crossover study.健康受试者口服10毫克、20毫克和40毫克伊拉普唑以及40毫克埃索美拉唑的药代动力学、药效学和安全性:一项随机、开放标签交叉研究。
Aliment Pharmacol Ther. 2014 Sep;40(5):548-61. doi: 10.1111/apt.12860. Epub 2014 Jul 13.

引用本文的文献

1
Analgosedation in paediatric severe traumatic brain injury (TBI): practice, pitfalls and possibilities.小儿重症创伤性脑损伤的镇痛镇静:实践、陷阱与可能性
Childs Nerv Syst. 2017 Oct;33(10):1703-1710. doi: 10.1007/s00381-017-3520-0. Epub 2017 Sep 6.

本文引用的文献

1
Evaluation of the predictive performance of four pharmacokinetic models for propofol.四种丙泊酚药代动力学模型预测性能的评估。
Br J Anaesth. 2009 May;102(5):626-32. doi: 10.1093/bja/aep043. Epub 2009 Mar 18.
2
Thiopental-induced neutropenia in two patients with severe head trauma.两名重度颅脑损伤患者出现硫喷妥钠所致中性粒细胞减少症。
Pharmacotherapy. 2007 Mar;27(3):464-71. doi: 10.1592/phco.27.3.464.
3
Rhabdomyolysis causing AV blockade due to possible atorvastatin, esomeprazole, and clarithromycin interaction.横纹肌溶解症导致房室传导阻滞,可能是由于阿托伐他汀、埃索美拉唑和克拉霉素相互作用所致。
Ann Pharmacother. 2003 Jun;37(6):808-11. doi: 10.1345/aph.1C396.
4
Prolonged thiopentone infusion for neurosurgical emergencies: usefulness of therapeutic drug monitoring.
Anaesth Intensive Care. 2001 Aug;29(4):339-48. doi: 10.1177/0310057X0102900403.
5
Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy.
Anesthesiology. 1999 Dec;91(6):1693-702. doi: 10.1097/00000542-199912000-00022.
6
Pharmacodynamics and pharmacokinetics of thiopental.硫喷妥钠的药效学与药代动力学。
Clin Pharmacokinet. 1998 Aug;35(2):95-134. doi: 10.2165/00003088-199835020-00002.
7
Thiopental in CSF and serum correlates with prolonged loss of cortical activity.
Eur Neurol. 1998;39(4):223-8. doi: 10.1159/000007938.
8
Time-dependent pharmacokinetics of high dose thiopental infusion in intensive care patients.重症监护患者大剂量硫喷妥钠输注的时间依赖性药代动力学
Pharm Res. 1997 Nov;14(11):1583-8. doi: 10.1023/a:1012130402199.
9
Population pharmacokinetics of high-dose thiopental in patients with cerebral injuries.大剂量硫喷妥钠在脑损伤患者中的群体药代动力学。
Clin Pharmacol Ther. 1997 Jul;62(1):15-20. doi: 10.1016/S0009-9236(97)90147-8.
10
Pharmacokinetics of high-dose thiopental in pediatric patients with increased intracranial pressure.
Ther Drug Monit. 1997 Feb;19(1):63-70. doi: 10.1097/00007691-199702000-00011.